Jan 28 2025
Healthcare
Recent Research
hVIVO, New contract win
Jan 21 2025
CVS Group, Trading statement
Nov 20 2024
Malin Corporation, Tender offer details
Nov 12 2024
Meet your Healthcare Research team
Uniphar
Stronger-than-expected organic growth drives an improved outlook
Uniphar’s trading update for FY2024 outlines stronger-than-expected growth in gross profits and EPS. Strong cashflows mean net debt is materially below forecast. Confidence in hitting...
hVIVO
New contract win
hVIVO has announced that hLAB, its standalone laboratory service provider, has won a new £2.7m laboratory contract – its largest standalone lab contract to date. This positive news...
hVIVO
Positive contract win and reiteration of FY2024 guidance
hVIVO has announced that it has won a contract for £11.5m with an existing top-tier global pharma customer. This will involve a human challenge study to test the customer’s antiviral...
Malin Corporation
Sale of Poseida unlocks significant value
Malin’s investee company, Poseida, which is listed in the US, is being acquired by Roche – triggering a substantial cash payment to Malin and upside in its intrinsic value. The tender offer...
CVS Group
Trading statement
CVS has issued a trading statement ahead of its AGM later today. Earnings growth in the first four months of FY2025 slowed, but the company remains confident of achieving full year...
Malin Corporation
Tender offer details
Malin has announced the details of its €45m tender offer, which is taking place post the disposal of its successful investment in CG Oncology. The tender price is set at €6.55 per...
hVIVO
Launch of hLAB standalone services
hVIVO has announced the launch of its hLAB service offering. This is a standalone business that it can offer for virology and immunology services. It follows the tripling of the...
CVS Group
FY2024 results reflect a challenging year but with strong growth ahead
CVS had previously given many of the key figures for FY2024 to June 30th in its July trading statement. In its FY results this morning, the company outlined that it is comfortable with...
hVIVO
H1 2024 results reflect record revenues and margins
hVIVO has reported strong H1 2024 results. Many of the key figures were provided in its trading statement on July 17th. H1 has seen very strong revenue growth and margin expansion...
Uniphar
H1 results support the outlook for a return to double-digit EPS growth this year
Uniphar’s H1 2024 results reflect strong top line and gross profit growth. All divisions are expected to achieve their growth targets this year. Ongoing investments support the...
